更正：研究内皮细胞体细胞 TIE2L914F 突变的人类 iPSC 和 CRISPR 靶向基因敲入策略。

IF 9.2 1区医学 Q1 PERIPHERAL VASCULAR DISEASE

Angiogenesis Pub Date : 2024-06-26 DOI:10.1007/s10456-024-09932-w

Bojana Lazovic, Hoang-Tuan Nguyen, Mohammadhassan Ansarizadeh, Leif Wigge, Franziska Kohl, Songyuan Li, Miguel Carracedo, Jere Kettunen, Luc Krimpenfort, Ramy Elgendy, Kati Richter, Laknee De Silva, Bilada Bilican, Prateek Singh, Pratik Saxena, Lars Jakobsson, Xuechong Hong, Lauri Eklund, Ryan Hicks

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Angiogenesis PERIPHERAL VASCULAR DISEASE-

CiteScore

21.90

自引率

8.20%

发文量

审稿时长

6-12 weeks

期刊介绍： Angiogenesis, a renowned international journal, seeks to publish high-quality original articles and reviews on the cellular and molecular mechanisms governing angiogenesis in both normal and pathological conditions. By serving as a primary platform for swift communication within the field of angiogenesis research, this multidisciplinary journal showcases pioneering experimental studies utilizing molecular techniques, in vitro methods, animal models, and clinical investigations into angiogenic diseases. Furthermore, Angiogenesis sheds light on cutting-edge therapeutic strategies for promoting or inhibiting angiogenesis, while also highlighting fresh markers and techniques for disease diagnosis and prognosis.